India pharma companies’ progress in complex generics, stable US pricing and steady sales growth in India led to fund houses buying into stocks like Alembic Pharma, Divis Labs, Glenmark, Medplus, Orchid and Sanofi Consumer.
GIFT Nifty hits record open interest of $21.56 billion; contracts touch all-time high
GIFT Nifty has hit a record open interest of $21.56 billion, reflecting rising global investor participation in India’s offshore derivatives market. The milestone, achieved on